Ledger.Open graph →
SEC Form D · filed August 7, 2020

ALPINE IMMUNE SCIENCES, INC

Offering
$82.7M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Paul P. Sekhri · Seattle, WADirectorRobert P. Conway · SEATTLE, WADirectorCui P. Xiangmin · SEATTLE, WADirectorJames P. Topper · SEATTLE, WADirectorJay P. Venkatesan · SEATTLE, WADirectorJames P. Rickey · Seattle, WAExecPeter P. Thompson · SEATTLE, WADirectorMitchell P. Gold · Seattle, WAExec · DirectorStanford P. Peng · SEATTLE, WAExecChristopher P. Peetz · SEATTLE, WADirectorRobert P. Conway · SEATTLE, WADirectorPaul P. Sekhri · Seattle, WADirectorCui P. Xiangmin · SEATTLE, WADirectorJames P. Topper · SEATTLE, WADirectorJay P. Venkatesan · SEATTLE, WADirectorJames P. Rickey · Seattle, WAExecPeter P. Thompson · SEATTLE, WADirectorMitchell P. Gold · Seattle, WAExec · DirectorStanford P. Peng · SEATTLE, WAExecChristopher P. Peetz · SEATTLE, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗